IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma.
Mengxiang ZhaoYijia HeNisha ZhuYuxian SongQingang HuZhiyong WangYan-Hong NiLiang DingPublished in: British journal of cancer (2022)
OSCC patients might benefit from anti-PD-1/L1 therapy.